Zkusit zdarma
Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc.

TRVI
Cena:
$ 14.13
-0.03 (-0.21%)
Valuace
70
Růst
45
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Trevi Therapeutics, Inc. (TRVI) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Trevi Therapeutics, Inc. (TRVI) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

22:10 12-05-2026

Trevi Therapeutics, Inc. (TRVI) Presents at Bank of America Global Healthcare Conference 2026 Prepar...

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030

5:07 09-05-2026

Trevi Therapeutics NASDAQ: TRVI outlined plans to advance Haduvio, its extended-release formulation ...

Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript

6:01 06-05-2026

Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript...

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

16:05 05-05-2026

Completed follow-on common stock offering with net proceeds of ~$162 million, extending expected cas...

Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

16:05 28-04-2026

NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

Trevi Therapeutics to Participate in Upcoming May Events

Trevi Therapeutics to Participate in Upcoming May Events

16:05 23-04-2026

NEW HAVEN, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc.  (Nasdaq: TRVI), a c...

Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

16:05 20-04-2026

NEW HAVEN, Conn., April 20, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

What's Going On With Trevi Therapeutics Stock?

What's Going On With Trevi Therapeutics Stock?

11:41 17-04-2026

Trevi Therapeutics, Inc. (NASDAQ: TRVI) shares are trading higher after the company announced the pr...

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

22:42 16-04-2026

NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

16:08 16-04-2026

NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

SG Americas Securities LLC Has $1.56 Million Stock Position in Trevi Therapeutics, Inc. $TRVI

SG Americas Securities LLC Has $1.56 Million Stock Position in Trevi Therapeutics, Inc. $TRVI

5:05 07-04-2026

SG Americas Securities LLC raised its stake in Trevi Therapeutics, Inc. (NASDAQ: TRVI) by 93.0% in t...

Trevi Therapeutics to Participate in Upcoming Events

Trevi Therapeutics to Participate in Upcoming Events

7:30 01-04-2026

NEW HAVEN, Conn., April 01, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of “Buy” from Analysts

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of “Buy” from Analysts

4:24 28-03-2026

Trevi Therapeutics, Inc. (NASDAQ: TRVI - Get Free Report) has earned an average recommendation of "B...

Head-To-Head Review: Trevi Therapeutics (NASDAQ:TRVI) vs. DNAPrint Genomics (OTCMKTS:DNAG)

Head-To-Head Review: Trevi Therapeutics (NASDAQ:TRVI) vs. DNAPrint Genomics (OTCMKTS:DNAG)

1:28 28-03-2026

Trevi Therapeutics (NASDAQ: TRVI - Get Free Report) and DNAPrint Genomics (OTCMKTS:DNAG - Get Free R...

Trevi Therapeutics Q4 Earnings Call Highlights

Trevi Therapeutics Q4 Earnings Call Highlights

4:16 20-03-2026

Trevi Therapeutics (NASDAQ: TRVI) used its fourth-quarter and year-end 2025 earnings call to outline...

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

16:05 17-03-2026

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 progr...

Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026

Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026

16:05 10-03-2026

NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clin...

Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough

Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough

7:30 09-03-2026

T he Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients...

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?

10:55 23-02-2026

The mean of analysts' price targets for Trevi Therapeutics (TRVI) points to a 102.1% upside in the s...

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA)

12:30 22-01-2026

Statistically-s ignificant reduction in the relative change from baseline in 24-hour objective cough...

close

TREVI THERAPEUTICS ANNOUNCES PUBLICATION OF DATA FROM THE PHASE 2B IPF CHRONIC COUGH TRIAL OF NALBUPHINE ER IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA)

22-01-2026
STATISTICALLY-S IGNIFICANT REDUCTION IN THE RELATIVE CHANGE FROM BASELINE IN 24-HOUR OBJECTIVE COUGH...
Více zde

TREVI THERAPEUTICS PROVIDES STRATEGIC UPDATES AHEAD OF ANNUAL LIFESCI PARTNERS CORPORATE ACCESS EVENT HELD DURING THE J.P. MORGAN HEALTHCARE CONFERENCE

08-01-2026
FDA END-OF-PHASE 2 MEETING SCHEDULED TO TAKE PLACE IN THE FIRST QUARTER OF 2026 FOR THE CHRONIC COUG...
Více zde

TREVI THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID HASTINGS AS CHIEF FINANCIAL OFFICER

04-12-2025
EXPERIENCED BIOTECH CFO TO LEAD FINANCIAL STRATEGY AND CONTRIBUTE TO THE COMPANY'S NEXT STAGE OF GRO...
Více zde

TREVI THERAPEUTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

13-11-2025
COMPANY PREPARING TO INITIATE COMPREHENSIVE PHASE 3 PROGRAM FOR CHRONIC COUGH IN PATIENTS WITH IDIOP...
Více zde

TREVI THERAPEUTICS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON NOVEMBER 13, 2025

06-11-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 4:30 P.M. ET NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN STIFEL 2025 HEALTHCARE CONFERENCE

04-11-2025
FIRESIDE CHAT WITH MANAGEMENT ON TUESDAY, NOVEMBER 11, 2025, AT 3:20 P.M. ET NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS ANNOUNCES ORAL PRESENTATION AND ABSTRACTS AT CHEST 2025 ANNUAL MEETING

08-10-2025
PROFESSOR PHILIP MOLYNEAUX WILL GIVE AN ORAL PRESENTATION ON THE KEY EFFICACY AND SAFETY RESULTS FRO...
Více zde

TREVI THERAPEUTICS ANNOUNCES TWO POSTERS FROM THE PHASE 2A RIVER TRIAL DATA WILL BE FEATURED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) CONGRESS 2025

18-09-2025
NEW HAVEN, CONN. , SEPT. 18, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINI...
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN UPCOMING SEPTEMBER CONFERENCES

28-08-2025
NEW HAVEN, CONN. , AUG. 28, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICA...
Více zde

TREVI THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

07-08-2025
ANNOUNCED POSITIVE TOPLINE RESULTS FROM ITS PHASE 2B CORAL TRIAL OF HADUVIO FOR THE TREATMENT OF CHR...
Více zde

TREVI THERAPEUTICS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON AUGUST 7, 2025

31-07-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 4:30 P.M. ET   NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN UPCOMING AUGUST CONFERENCES

29-07-2025
NEW HAVEN, CONN. , JULY 29, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINIC...
Více zde

TREVI THERAPEUTICS TO ATTEND LEERINK PARTNERS THERAPEUTICS FORUM: I&I AND METABOLISM

01-07-2025
NEW HAVEN, CONN. , JULY 1, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICAL...
Více zde

TRVI STOCKHOLDER ALERT: KASKELA LAW LLC ANNOUNCES INVESTIGATION OF TREVI THERAPEUTICS, INC. (NASDAQ: TRVI) AND ENCOURAGES LONG-TERM INVESTORS TO CONTACT THE FIRM

26-06-2025
PHILADELPHIA, JUNE 26, 2025 (GLOBE NEWSWIRE) -- KASKELA LAW LLC ANNOUNCES THAT IT IS INVESTIGATING T...
Více zde

TREVI THERAPEUTICS ANNOUNCES CLOSING OF $115 MILLION UNDERWRITTEN OFFERING AND FULL EXERCISE BY UNDERWRITERS OF OPTION TO PURCHASE ADDITIONAL SHARES

05-06-2025
NEW HAVEN, CONN. , JUNE 5, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICAL...
Více zde

TREVI THERAPEUTICS ANNOUNCES PRICING OF $100 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK

03-06-2025
NEW HAVEN, CONN. , JUNE 3, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICA...
Více zde

TREVI THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

02-06-2025
NEW HAVEN, CONN. , JUNE 2, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICAL-...
Více zde

TREVI THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE PHASE 2B CORAL TRIAL OF HADUVIO IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS CHRONIC COUGH

02-06-2025
HADUVIO MET THE PRIMARY ENDPOINT WITH STATISTICALLY-SIGNIFICANT REDUCTIONS IN 24-HOUR COUGH FREQUENC...
Více zde

TREVI THERAPEUTICS TO HOST CONFERENCE CALL AND WEBCAST ON JUNE 2ND TO SHARE TOPLINE RESULTS FROM THE PHASE 2B CORAL TRIAL OF HADUVIO IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS CHRONIC COUGH

01-06-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 8:30 A.M. ET   NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN UPCOMING JUNE CONFERENCES

29-05-2025
NEW HAVEN, CONN. , MAY 29, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC.  (NASDAQ: TRVI), A CLINICA...
Více zde

TREVI THERAPEUTICS ANNOUNCES ADDITIONAL ANALYSES FROM PHASE 2A RIVER TRIAL OF HADUVIO IN PATIENTS WITH REFRACTORY CHRONIC COUGH

20-05-2025
RESULTS OF ANALYSES PRESENTED AT AN INVESTOR MEETING DURING THE AMERICAN THORACIC SOCIETY 2025 INTER...
Více zde

TREVI THERAPEUTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

08-05-2025
COMPLETED ENROLLMENT AND LAST PATIENT LAST VISIT IN THE PHASE 2B CORAL TRIAL IN IPF PATIENTS WITH CH...
Více zde

TREVI THERAPEUTICS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MAY 8, 2025

01-05-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 4:30 P.M. ET   NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN UPCOMING APRIL INVESTOR CONFERENCES

03-04-2025
NEW HAVEN, CONN. , APRIL 3, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINICA...
Více zde

TREVI THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

18-03-2025
ANNOUNCED POSITIVE TOPLINE DATA FROM THE PHASE 2A RIVER TRIAL IN PATIENTS WITH REFRACTORY CHRONIC CO...
Více zde

TREVI THERAPEUTICS TO REPORT FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MARCH 18, 2025

11-03-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 4:30 P.M. ET NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM THE PHASE 2A RIVER TRIAL OF HADUVIO IN PATIENTS WITH REFRACTORY CHRONIC COUGH

10-03-2025
HADUVIO MET THE PRIMARY ENDPOINT WITH A STATISTICALLY-SIGNIFICANT REDUCTION (P...
Více zde

TREVI THERAPEUTICS TO HOST CONFERENCE CALL AND WEBCAST ON MARCH 10TH TO SHARE TOPLINE RESULTS FROM THE PHASE 2A RIVER TRIAL OF HADUVIO IN PATIENTS WITH REFRACTORY CHRONIC COUGH

09-03-2025
CONFERENCE CALL AND WEBCAST TO BE HELD AT 8:30 A.M. ET   NEW HAVEN, CONN....
Více zde

TREVI THERAPEUTICS TO PARTICIPATE IN UPCOMING MARCH INVESTOR CONFERENCES

27-02-2025
NEW HAVEN, CONN. , FEB. 27, 2025 /PRNEWSWIRE/ -- TREVI THERAPEUTICS, INC. (NASDAQ: TRVI), A CLINIC...
Více zde

TREVI THERAPEUTICS COMPLETES ENROLLMENT FOR PHASE 2B CORAL TRIAL OF HADUVIO IN IDIOPATHIC PULMONARY FIBROSIS PATIENTS WITH CHRONIC COUGH

25-02-2025
TOPLINE RESULTS CONTINUE TO BE EXPECTED IN THE FIRST HALF OF 2025 NEW HAVEN, CONN. , FEB. 25, 2025 /...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-05 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-13 00:00:0010-QStáhnout
2025-08-20 01:00:008-KStáhnout
2025-08-20 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-03-18 00:00:008-KStáhnout
2025-03-18 00:00:0010-KStáhnout
2025-03-17 23:00:008-KStáhnout
2025-03-17 23:00:0010-KStáhnout
2025-03-10 00:00:008-KStáhnout
2025-03-09 23:00:008-KStáhnout
2025-01-08 00:00:008-KStáhnout
2025-01-07 23:00:008-KStáhnout
2024-12-16 00:00:008-KStáhnout
2024-12-15 23:00:008-KStáhnout
2024-12-12 00:00:008-KStáhnout
2024-12-11 23:00:008-KStáhnout
2024-12-03 00:00:008-KStáhnout
2024-12-02 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-10-21 01:00:008-KStáhnout
2024-10-21 00:00:008-KStáhnout
2024-10-04 01:00:008-KStáhnout
2024-10-04 00:00:008-KStáhnout
2024-10-01 01:00:008-KStáhnout
2024-10-01 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-13 01:00:008-KStáhnout
2024-06-13 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-03-20 00:00:008-KStáhnout
2024-03-20 00:00:0010-KStáhnout
2024-03-19 23:00:008-KStáhnout
2024-03-19 23:00:0010-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-29 01:00:008-KStáhnout
2023-06-29 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-04-14 01:00:008-KStáhnout
2023-04-14 00:00:008-KStáhnout
2023-03-16 00:00:008-KStáhnout
2023-03-16 00:00:0010-KStáhnout
2023-03-15 23:00:008-KStáhnout
2023-03-15 23:00:0010-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-09-23 01:00:008-KStáhnout
2022-09-23 00:00:008-KStáhnout
2022-09-19 01:00:008-KStáhnout
2022-09-19 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-29 01:00:008-KStáhnout
2022-06-29 00:00:008-KStáhnout
2022-06-23 01:00:008-KStáhnout
2022-06-23 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-04-07 01:00:008-KStáhnout
2022-04-07 00:00:008-KStáhnout
2022-03-17 00:00:008-KStáhnout
2022-03-17 00:00:0010-KStáhnout
2022-03-16 23:00:008-KStáhnout
2022-03-16 23:00:0010-KStáhnout
2022-03-16 00:00:008-KStáhnout
2022-03-15 23:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-01 00:00:008-KStáhnout
2022-01-31 23:00:008-KStáhnout
2022-01-14 00:00:008-KStáhnout
2022-01-13 23:00:008-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-10-19 01:00:008-KStáhnout
2021-10-19 00:00:008-KStáhnout
2021-10-01 01:00:008-KStáhnout
2021-10-01 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 00:00:008-KStáhnout
2021-07-09 01:00:008-KStáhnout
2021-07-09 00:00:008-KStáhnout
2021-07-07 01:00:008-KStáhnout
2021-07-07 00:00:008-KStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-04-02 01:00:008-KStáhnout
2021-04-02 00:00:008-KStáhnout
2021-03-25 00:00:008-KStáhnout
2021-03-25 00:00:0010-KStáhnout
2021-03-24 23:00:008-KStáhnout
2021-03-24 23:00:0010-KStáhnout
2021-03-22 00:00:008-KStáhnout
2021-03-21 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-10-21 01:00:008-KStáhnout
2020-10-21 00:00:008-KStáhnout
2020-09-11 01:00:008-KStáhnout
2020-09-11 00:00:008-KStáhnout
2020-08-13 01:00:008-KStáhnout
2020-08-13 01:00:0010-QStáhnout
2020-08-13 00:00:008-KStáhnout
2020-08-13 00:00:0010-QStáhnout
2020-07-13 01:00:008-KStáhnout
2020-07-13 00:00:008-KStáhnout
2020-06-30 01:00:008-KStáhnout
2020-06-30 00:00:008-KStáhnout
2020-06-17 01:00:008-KStáhnout
2020-06-17 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2020-02-18 00:00:008-KStáhnout
2020-02-17 23:00:008-KStáhnout
2020-01-06 00:00:008-KStáhnout
2020-01-05 23:00:008-KStáhnout
2019-11-14 00:00:008-KStáhnout
2019-11-14 00:00:0010-QStáhnout
2019-11-13 23:00:008-KStáhnout
2019-11-13 23:00:0010-QStáhnout
2019-09-24 01:00:008-KStáhnout
2019-09-24 00:00:008-KStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 01:00:0010-QStáhnout
2019-08-12 00:00:008-KStáhnout
2019-08-12 00:00:0010-QStáhnout
2019-07-02 01:00:008-KStáhnout
2019-07-02 00:00:008-KStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 01:00:0010-QStáhnout
2019-06-14 00:00:008-KStáhnout
2019-06-14 00:00:0010-QStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 00:00:008-KStáhnout
preloader